Renaissance Technologies (RenTech)'s ALXO Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 732,599 shares of ALX Oncology Holdings Inc. (ALXO) worth $1.47 M, representing 0.00% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ALXO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 309,500 shares. Largest reduction occurred in Q3 2024, reducing 282,900 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s ALX Oncology Holdings (ALXO) Holding Value Over Time
Track share changes against reported price movement
Quarterly ALX Oncology Holdings (ALXO) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +309,500 | Add 73.15% | 732,599 | $2.01 |
| Q4 2025 | +258,600 | Add 157.20% | 423,099 | $1.13 |
| Q3 2025 | +79,100 | Add 92.62% | 164,499 | $1.83 |
| Q2 2025 | +71,100 | Add 497.24% | 85,399 | $0.42 |
| Q1 2025 | +14,299 | New Buy | 14,299 | $0.62 |
| Q4 2024 | -155,300 | Sold Out | 0 | $0.00 |
| Q3 2024 | -282,900 | Reduce 64.56% | 155,300 | $1.82 |
| Q2 2024 | +204,100 | Add 87.18% | 438,200 | $6.03 |
| Q1 2024 | -36,400 | Reduce 13.46% | 234,100 | $11.15 |
| Q4 2023 | +58,000 | Add 27.29% | 270,500 | $14.89 |
| Q3 2023 | +29,700 | Add 16.25% | 212,500 | $4.80 |
| Q2 2023 | +55,981 | Add 44.14% | 182,800 | $0.01 |
| Q1 2023 | +31,019 | Add 32.38% | 126,819 | $0.00 |
| Q4 2022 | -74,800 | Reduce 43.85% | 95,800 | $0.01 |
| Q3 2022 | -57,083 | Reduce 25.07% | 170,600 | $9.57 |
| Q2 2022 | +78,883 | Add 53.01% | 227,683 | $8.09 |
| Q1 2022 | -19,100 | Reduce 11.38% | 148,800 | $16.90 |
| Q4 2021 | +167,900 | New Buy | 167,900 | $21.49 |
Renaissance Technologies (RenTech)'s ALX Oncology Holdings Investment FAQs
Renaissance Technologies (RenTech) first purchased ALX Oncology Holdings Inc. (ALXO) in Q4 2021, acquiring 167,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held ALX Oncology Holdings Inc. (ALXO) for 18 quarters since Q4 2021.
Renaissance Technologies (RenTech)'s largest addition to ALX Oncology Holdings Inc. (ALXO) was in Q1 2026, adding 732,599 shares worth $1.47 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 732,599 shares of ALX Oncology Holdings Inc. (ALXO), valued at approximately $1.47 M.
As of the Q1 2026 filing, ALX Oncology Holdings Inc. (ALXO) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in ALX Oncology Holdings Inc. (ALXO) was 732,599 shares, as reported at the end of Q1 2026.